Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers

Biomarkers. 2012 May;17(3):286-8. doi: 10.3109/1354750X.2012.657685. Epub 2012 Feb 7.

Abstract

Chaudhary and colleagues observed associations of matrix metalloproteinase (MMP)-2 (-1306C/T) and MMP-9 (-1562C/T) promoter polymorphisms with head and neck squamous cell carcinoma (HNSCC), but not with oral submucous fibrosis (OSMF) in an Indian population. We suggest that they could carry out a haplotype analysis with their data on MMP-2 genotypes (-1306C/T and -168G/T) and that they consider genotyping the microsatellite -90 (CA)(14-24) in the MMP-9 promoter region in order to perform haplotype analysis in combination with their data on MMP-9 (-1562C/T) polymorphism. These suggestions could provide additional information with clinical relevance to cancer susceptibility.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Squamous Cell / genetics*
  • Female
  • Head and Neck Neoplasms / genetics*
  • Humans
  • Male
  • Matrix Metalloproteinase 2 / genetics*
  • Matrix Metalloproteinase 9 / genetics*
  • Oral Submucous Fibrosis / genetics*
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic / genetics*

Substances

  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9